Fifteen years on, iPSC technology has become the basis for many drug development efforts, and it could one day change the outlook for millions of people. iPSC-based therapies could replace ...

Use Applied StemCell's (ASC) new GMP facility, comprised of five cleanrooms equipped with cutting-edge technology, to develop the next generation of iPSC-derived therapeutics. We have dedicated ...

Century Therapeutics (NASDAQ:IPSC – Free Report) had its target price decreased by Guggenheim from $12.00 to $5.00 in a research note published on Friday morning,Benzinga reports. Guggenheim ...

is a biotechnology company pioneering next generation approaches to cure neurological conditions. The Company utilizes induced pluripotent stem cell (iPSC) technology, a Nobel Prize-winning ...

This collaboration combines Cellino’s automated iPSC manufacturing with Matricelf ... to accelerate the commercialization of next-generation regenerative therapies for neurological diseases ...